Albemarle (ALB) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the latest close session, Albemarle (ALB) was down 2.28% at $156.69. The stock's performance was behind the S&P 500's daily loss of 0.37%. On the other hand, the Dow registered a gain of 0.29%, and the technology-centric Nasdaq decreased by 1.33%. Coming into today, shares of the specialty chemicals company had lost 6.55% in the past month. In that same time, the Basic Materials sector gained 3.31%, while the S&P 500 gained 2.02%. Investors will be eagerly watching for the performance of Albemarle in its upcoming earnings disclosure. The company is predicted to post an EPS of $3.08, indicating a 2700% growth compared to the equivalent quarter last year. Our most recent consensus estimate is calling for quarterly revenue of $1.48 billion, up 11.36% from the year-ago period. For the full year, the Zacks Consensus Estimates are projecting earnings of $12.39 per share and revenue of $5.99 billion, which would represent changes of +1668.35% and +16.45%, respectively, from the prior year. Investors should also pay attention to any latest changes in analyst estimates for Albemarle. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Our research demonstrates that these adjustments in estimates directly associate with imminent stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 7.74% higher. Albemarle is holding a Zacks Rank of #1 (Strong Buy) right now. With respect to valuation, Albemarle is currently being traded at a Forward P/E ratio of 12.94. Its industry sports an average Forward P/E of 15.51, so one might conclude that Albemarle is trading at a discount comparatively. It's also important to note that ALB currently trades at a PEG ratio of 0.81. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. The Chemical - Diversified was holding an average PEG ratio of 1.15 at yesterday's closing price. The Chemical - Diversified industry is part of the Basic Materials sector. At present, this industry carries a Zacks Industry Rank of 73, placing it within the top 30% of over 250 industries. The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use Zacks.com to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Radical New Technology Could Hand Investors Huge GainsQuantum Computing is the next technological revolution, and it could be even more advanced than AI.While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.See Top Quantum Stocks Now >>This article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks